Eupraxia Pharmaceuticals Files 6-K for September 2025
Ticker: EPRX · Form: 6-K · Filed: Sep 23, 2025 · CIK: 1581178
Sentiment: neutral
Topics: reporting, foreign-private-issuer, regulatory-filing
TL;DR
Eupraxia Pharma (EPRX) filed a 6-K for Sept '25, confirming 40-F annual report filing.
AI Summary
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 23, 2025, reporting for the month of September 2025. The company, headquartered in Victoria, British Columbia, Canada, is a foreign private issuer and is filing under the 1934 Securities Exchange Act. This filing indicates they will file annual reports under cover of Form 40-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Eupraxia Pharmaceuticals' reporting status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- EUPRAXIA PHARMACEUTICALS INC. (company) — Registrant
- 001-41923 (company) — Commission File Number
- 201-2067 Cadboro Bay Road Victoria, British Columbia, Canada V8R 5G4 (company) — Principal Executive Office Address
- 250-590-3968 (company) — Telephone Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of September 2025.
What is Eupraxia Pharmaceuticals Inc.'s commission file number?
Eupraxia Pharmaceuticals Inc.'s commission file number is 001-41923.
Where is Eupraxia Pharmaceuticals Inc. located?
Eupraxia Pharmaceuticals Inc.'s principal executive office is located at 201-2067 Cadboro Bay Road, Victoria, British Columbia, Canada V8R 5G4.
Does Eupraxia Pharmaceuticals Inc. file annual reports under Form 20-F or Form 40-F?
Eupraxia Pharmaceuticals Inc. indicates it will file annual reports under cover of Form 40-F.
What is the SIC code for Eupraxia Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Eupraxia Pharmaceuticals Inc. is 2834, Pharmaceutical Preparations.
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2025-09-23 11:07:04
Filing Documents
- f6k_092325.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 11KB
- 0001171843-25-006031.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. EUPRAXIA PHARMACEUTICALS INC. Date: September 22, 2025 By: /s/ Alex Rothwell Name: Alex Rothwell Title: Chief Financial Officer